^
Phase 3
Tolmar Inc.
Recruiting
Last update posted :
02/24/2025
Initiation :
07/01/2021
Primary completion :
04/30/2026
Completion :
04/30/2026
HER-2
|
HER-2 negative
|
tamoxifen • letrozole • anastrozole • exemestane • Eligard (leuprolide acetate)
Phase 2
Atossa Therapeutics, Inc.
Recruiting
Last update posted :
02/24/2025
Initiation :
02/14/2023
Primary completion :
02/01/2026
Completion :
09/01/2026
HER-2 • ER
|
HER-2 negative
|
exemestane • goserelin acetate
Phase 2
National Cancer Institute (NCI)
Recruiting
Last update posted :
02/12/2025
Initiation :
07/20/2023
Primary completion :
04/11/2027
Completion :
04/11/2027
AR
|
AR positive
|
Eligard (leuprolide acetate) • Nubeqa (darolutamide) • Viadur (leuprorelin implant)
Phase 2
Janssen Pharmaceutical K.K.
Active, not recruiting
Last update posted :
02/10/2025
Initiation :
04/07/2020
Primary completion :
06/09/2021
Completion :
12/31/2027
AR
|
AR positive
|
apalutamide • goserelin acetate
Phase N/A
Ipsen
Active, not recruiting
Last update posted :
01/31/2025
Initiation :
06/09/2022
Primary completion :
06/30/2026
Completion :
06/30/2026
HER-2 • BRCA1 • BRCA2 • BRCA
|
HR positive • HER-2 negative • HR positive + HER-2 negative • BRCA mutation
|
triptorelin
Phase 3
SWOG Cancer Research Network
Recruiting
Last update posted :
08/16/2024
Initiation :
09/24/2018
Primary completion :
04/01/2028
Completion :
10/01/2031
SYP
|
docetaxel • abiraterone acetate • prednisone • Eligard (leuprolide acetate) • bicalutamide • triptorelin • goserelin acetate • flutamide • nilutamide • Firmagon (degarelix) • Viadur (leuprorelin implant)
Phase 2
National Cancer Institute (NCI)
Suspended
Last update posted :
06/10/2024
Initiation :
02/08/2024
Primary completion :
05/31/2027
Completion :
05/31/2027
ER • PGR
|
exemestane • Eligard (leuprolide acetate) • Nubeqa (darolutamide) • Viadur (leuprorelin implant)
Phase 3
NRG Oncology
Recruiting
Last update posted :
02/07/2024
Initiation :
12/15/2020
Primary completion :
12/31/2033
Completion :
12/31/2033
CD4
|
abiraterone acetate • bicalutamide • apalutamide • triptorelin • goserelin acetate • flutamide • Firmagon (degarelix) • leuprolide acetate for depot suspension • Suprefact (buserelin acetate) • Yonsa (abiraterone acetate)
Phase 3
ETOP IBCSG Partners Foundation
Active, not recruiting
Last update posted :
01/01/2024
Initiation :
11/03/2003
Primary completion :
03/11/2011
Completion :
12/01/2025
PGR
|
HR positive • PGR positive
|
tamoxifen • exemestane • triptorelin
Phase N/A
Hongmei Zheng
Recruiting
Last update posted :
10/11/2023
Initiation :
09/01/2023
Primary completion :
09/01/2028
Completion :
09/01/2028
HER-2
|
HER-2 positive • HR positive • HER-2 negative • HR positive + HER-2 negative
|
goserelin acetate
Phase 2
The Netherlands Cancer Institute
Recruiting
Last update posted :
10/06/2023
Initiation :
02/15/2023
Primary completion :
11/01/2024
Completion :
11/01/2025
FOLH1
|
FOLH1 expression
|
triptorelin
Phase 1/2
University of Michigan Rogel Cancer Center
Recruiting
Last update posted :
09/14/2023
Initiation :
11/06/2020
Primary completion :
11/01/2026
Completion :
05/01/2027
DRD
|
DDR • DRD
|
Zejula (niraparib) • abiraterone acetate • leuprolide acetate for depot suspension
Phase 2/3
Tianjin Medical University Cancer Institute and...
Recruiting
Last update posted :
08/24/2023
Initiation :
04/11/2023
Primary completion :
03/11/2025
Completion :
09/11/2026
HER-2 • ER
|
ER positive • HER-2 negative • HER-2 expression • PGR expression
|
cyclophosphamide • epirubicin • exemestane • goserelin acetate
Phase N/A
Peking University People's Hospital
Recruiting
Last update posted :
07/14/2023
Initiation :
08/01/2016
Primary completion :
12/31/2023
Completion :
12/31/2027
TP53 • PTEN • MLH1 • MSH6 • MSH2
|
TP53 expression
|
triptorelin • goserelin acetate • megestrol
Phase N/A
ETOP IBCSG Partners Foundation
Active, not recruiting
Last update posted :
05/31/2023
Initiation :
08/03/2009
Primary completion :
03/11/2011
Completion :
12/01/2025
IGF1 • IGFBP3
|
HR positive
|
tamoxifen • exemestane • triptorelin
Phase 4
Gangnam Severance Hospital
Recruiting
Last update posted :
02/09/2023
Initiation :
02/06/2023
Primary completion :
01/01/2028
Completion :
01/01/2033
HER-2 • ER
|
HER-2 negative
|
tamoxifen • goserelin acetate
Phase 2
Shanghai Jiao Tong University School of Medicine
Completed
Last update posted :
12/30/2022
Initiation :
05/01/2015
Primary completion :
12/01/2021
Completion :
12/01/2021
ER • PGR
|
anastrozole • exemestane • goserelin acetate
Phase 3
Peking University
Recruiting
Last update posted :
11/29/2021
Initiation :
07/29/2015
Primary completion :
06/30/2026
Completion :
12/31/2026
HER-2 • PGR
|
HER-2 negative • PGR positive
|
epirubicin • goserelin acetate
Phase N/A
Fudan University
Not yet recruiting
Last update posted :
11/16/2021
Initiation :
11/01/2021
Primary completion :
02/01/2024
Completion :
04/01/2024
HER-2
|
HER-2 negative
|
goserelin acetate • leuprolide acetate for depot suspension
Phase N/A
ETOP IBCSG Partners Foundation
Completed
Last update posted :
10/25/2021
Initiation :
11/25/2008
Primary completion :
12/01/2016
Completion :
12/01/2016
ER • PGR
|
PGR positive
|
tamoxifen • exemestane • triptorelin • Soltamox (tamoxifen citrate)
Phase N/A
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Un...
Not yet recruiting
Last update posted :
05/18/2021
Initiation :
05/01/2021
Primary completion :
05/01/2023
Completion :
09/01/2023
ER
|
PGR expression
|
tamoxifen • exemestane • leuprolide acetate for depot suspension
Phase 3
AstraZeneca
Withdrawn
Last update posted :
05/10/2021
Initiation :
03/31/2020
Primary completion :
11/04/2021
Completion :
11/04/2021
HER-2 • ER
|
HER-2 negative
|
goserelin acetate
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
03/18/2021
Initiation :
04/19/2011
Primary completion :
12/01/2017
Completion :
11/19/2020
FLT3 • ABL1 • BCR • KMT2A • HLA-DRB1 • HLA-B • HLA-C
|
MLL rearrangement • MLL rearrangement
|
cyclophosphamide • methotrexate • fludarabine IV • busulfan • leuprolide acetate for depot suspension • cyclophosphamide intravenous
Phase 2
Roswell Park Cancer Institute
Completed
Last update posted :
11/03/2020
Initiation :
09/01/2009
Primary completion :
10/05/2018
Completion :
10/05/2019
CD8 • CD4
|
HLA-A2 positive
|
goserelin acetate
Phase 3
Southwest Oncology Group
Completed
Last update posted :
12/30/2019
Initiation :
10/01/2003
Primary completion :
01/01/2014
Completion :
09/01/2016
ER • PGR
|
ER negative • PGR negative
|
cyclophosphamide • goserelin acetate
Phase 2
M.D. Anderson Cancer Center
Completed
Last update posted :
10/16/2019
Initiation :
11/01/2005
Primary completion :
10/01/2012
Completion :
10/01/2012
CD8
|
leuprolide acetate for depot suspension
Phase 2
Stanford University
Completed
Last update posted :
10/07/2019
Initiation :
10/01/2000
Primary completion :
05/01/2013
Completion :
06/01/2013
PGR
|
anastrozole • goserelin acetate
Phase 3
Ipsen
Completed
Last update posted :
01/30/2019
Initiation :
11/01/2009
Primary completion :
11/01/2011
Completion :
06/01/2013
ERG • TMPRSS2 • PCA3
|
triptorelin
Phase 3
AstraZeneca
Completed
Last update posted :
12/12/2018
Initiation :
02/26/2010
Primary completion :
09/19/2012
Completion :
11/20/2017
ER
|
ER positive
|
tamoxifen • goserelin acetate
Phase 2
Tianjin Medical University Second Hospital
Recruiting
Last update posted :
10/09/2018
Initiation :
08/01/2018
Primary completion :
08/01/2022
Completion :
08/01/2023
BRAF
|
carboplatin • docetaxel • goserelin acetate
Phase 2
Kasr El Aini Hospital
Not yet recruiting
Last update posted :
02/23/2018
Initiation :
03/01/2018
Primary completion :
03/01/2021
Completion :
03/01/2023
HER-2 • PGR • AR
|
HER-2 negative • AR positive • PGR negative
|
doxorubicin hydrochloride • cyclophosphamide • goserelin acetate
Phase 3
Peking Union Medical College Hospital
Completed
Last update posted :
10/17/2017
Initiation :
06/01/2015
Primary completion :
11/01/2016
Completion :
11/01/2016
HER-2
|
HER-2 overexpression
|
paclitaxel • cyclophosphamide • goserelin acetate
Phase 3
Fudan University
Completed
Last update posted :
08/25/2017
Initiation :
06/01/2009
Primary completion :
08/01/2017
Completion :
08/01/2017
ER • PGR
|
HR positive • ER negative • PGR positive • PGR expression
|
tamoxifen • goserelin acetate
Phase N/A
Sir Mortimer B. Davis - Jewish General Hospital
Not yet recruiting
Last update posted :
07/28/2016
Initiation :
12/01/2016
Primary completion :
01/01/2030
ERG • TMPRSS2
|
TMPRSS2-ERG fusion
|
Eligard (leuprolide acetate) • triptorelin • goserelin acetate • leuprolide acetate for depot suspension
Phase 2
NYU Langone Health
Completed
Last update posted :
03/11/2016
Initiation :
06/01/2000
Primary completion :
05/01/2001
PGR
|
ER positive + PGR positive • PGR positive
|
exemestane • goserelin acetate
Phase 3
King Faisal Specialist Hospital & Research Center
Completed
Last update posted :
02/25/2016
Initiation :
11/01/2009
Primary completion :
11/01/2012
Completion :
11/01/2012
PGR
|
ER negative • PGR negative
|
cyclophosphamide • goserelin acetate
Phase 3
Takeda
Completed
Last update posted :
11/26/2015
Initiation :
04/01/2012
Primary completion :
12/01/2014
Completion :
12/01/2014
HER-2 • ER • PGR
|
ER positive • HER-2 negative
|
leuprolide acetate for depot suspension